In-vitro diagnostic substance manufacturing - GEM-x universal 3' gene expression V4, 4 samples and chromium GEM-x single cell 3' chip kit V4, 4 chips
Ended Awarded
- Contract number
- 75N95D25F40036
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,302
Award facts
- Contract value 100% obligated
- $19,301.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute on Aging awarded a firm fixed-price delivery order valued at $19,301.77 to 10X Genomics, Inc. for in-vitro diagnostic substance manufacturing on September 19, 2025, with an ultimate completion date of October 13, 2025. The order encompasses GEM-X Universal 3' Gene Expression V4 samples (4 units) and Chromium GEM-X Single Cell 3' Chip Kit V4 products (4 chips) to be performed at 10X Genomics' Pleasanton, California facility. This delivery order was issued without a set-aside designation and represents specialized genomic analysis consumables supporting the National Institute on Aging's biomedical research mission.
This delivery order falls under a larger indefinite delivery contract with the National Institute on Aging valued at up to $7 million through July 2029, which focuses on providing optimization slides, reagent kits, and reagent delivery methods for neurological disease research. 10X Genomics, a biotechnology leader in single-cell and spatial transcriptomics platforms, has been a critical supplier to multiple National Institutes of Health agencies, including the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of Neurological Disorders and Stroke. Under this broader contract vehicle, the National Institute on Aging has issued multiple firm fixed-price delivery orders for advanced genomic analysis products that enable cutting-edge molecular research across diverse scientific domains.
Quick answers
Who was awarded contract 75N95D25F40036?
75N95D25F40036 was awarded to 10X Genomics, Inc. by National Institute on Aging (National Institutes of Health) on September 19, 2025.
How much is contract 75N95D25F40036 worth?
The government has obligated $19,302 on 75N95D25F40036.
Is contract 75N95D25F40036 an order under another contract?
Yes. 75N95D25F40036 is a delivery order under 75N95024D00029, an indefinite delivery contract.
Was contract 75N95D25F40036 competed?
The extent of competition for 75N95D25F40036 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award